GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
https://you tu.be/Rulbe6djZk4
Hopefully this time, remove the space
Hmm why can't I share links?
https://youtu.be/Rulbe6djZk4
See past 2mins in, Marc predicts covid to remain in the population for decades and is running trails on anti-TNF on treating covid.
But they have 149m shares in issue and we have 434m so for us to rise to £2.38 we need £1b market cap, whereas sng is only £350m market cap?
Yes I can smell the collaboration already!!
That's just not true apple EUA grow from 0.45 to 23 over 10 months from October 19 to August 20.
No worries I guess I misunderstood. My plan is to slice a very tiny portion and buy back so I can round off my holding. I've put everything into hemo now so I can't just buy any more shares to round it off.
Maybe you're losing faith because Vlad never replied to you on Twitter :(
That post is such a massive contradiction to everything you have every posted on the hemo board. Out at 20p!?
A strong license agreement of say £30-50m upfront and £300-500m in milestones will see this at 50p+
Very low*
Does anyone know when we should expect the normal market size to be recalculated? 50,000 is very compared to the last 3 months average daily volume
It is the optimistic view that at the start of September after the CDX agreement with is complete that the licence deal is announced very shortly after if not on the same day. But assuming no further extension there is still the possibility of the licensing deal not finalized until start of December.
It's not even a disagreement, it's just true of course it's hard to quantify potential!
I do believe hemo has huge potential which is why my money is here.
Seeing the value of upfront payment on the CDX deal will tell us what's the new low range for the SP. Look at REDX current price for an example barely higher than pre-news price + upfront payment, because the milestones are for now potential.
I did and I've already read it a few times before
Just because a value gets assigned doesn't mean it's the right value. Optimistic values get placed all the time and companies have writedowns and impairments. So yes it is very hard.
I agree there is so much potential in hemo, with multiple products candidates showing positive signs. Hemos ability to collaborate with such academic and industry heavy weights is proof in itself of the opportunity here. But it's very hard to put numbers on potential.
You're right it's big news and everyone should be pleased. But as the RNS said it's a first step, very far away from commercialisation and an increase to the company cash burn. The share price has come a long way in a short time and no long term holders can be disappointed.
Plenty more to come, CDX deal with numbers will cause a huge increase. I'm looking forward to seeing a revenue number in the half year results which should be end of September.